NOVOCURE LTD - NOTE 11/0

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Debt / NOTE 11/0
Market price (% of par)
89.14%
Total 13F principal
$408,289,989
Principal change
-$14,640,207
Total reported market value
$374,333,508
Number of holders
31
Value change
-$9,896,401
Number of buys
12
Number of sells
11

Institutional Holders of NOVOCURE LTD - NOTE 11/0 as of Q3 2022

As of 30 Sep 2022, NOVOCURE LTD - NOTE 11/0 was held by 31 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $408,289,989 in principal (par value) of the bond. The largest 10 bondholders included Voya Investment Management LLC, WOLVERINE ASSET MANAGEMENT LLC, STEELHEAD PARTNERS LLC, DeepCurrents Investment Group LLC, Verition Fund Management LLC, CAPSTONE INVESTMENT ADVISORS, LLC, Aequim Alternative Investments LP, CALAMOS ADVISORS LLC, Empyrean Capital Partners, LP, and SHENKMAN CAPITAL MANAGEMENT INC. This page lists 31 institutional bondholders reporting positions for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.